RAPT Therapeutics, Inc.

RAPT

RAPT Therapeutics, Inc.

RAPT

Insider Sentiment (TTM):

Last Purchase:2023-03-14Last Sale:2024-01-05Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:27,167,153Shares Outstanding:26,963,107Institutional Ownership Pct.:100.76%

Earnings Market Reaction:

Filing Date:2025-11-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Cash And Cash Equivalents At Carrying Value	38	42	60	170	38	37	45	47	54	50	46	39
Assets Current
Assets Current	161	173	183	235	103	120	148	162	187	207	235	253
Marketable Securities Current	119	127	119	61	60	78	96	111	131	155	186	210
Prepaid Expense And Other Assets Current	4	4	4	4	5	6	7	3	2	2	3	4
Property Plant And Equipment Net	1	1	1	1	2	2	2	2	3	3	3	3
Operating Lease Right Of Use Asset	2	2	3	3	4	4	5	5	6	6	7	7
Other Assets Noncurrent	2	2	0	0	0	0	0	4	4	4	4	4
Assets	166	178	188	240	108	127	156	173	200	221	248	266
Liabilities And Stockhold…
Accounts Payable Current	2	4	1	1	1	3	7	5	5	3	9	3
Accrued Liabilities Current	9	7	5	10	6	9	12	14	14	10	10	9
Liabilities Current
Liabilities Current	13	13	9	48	10	15	21	22	22	15	22	14
Operating Lease Liability Current	2	2	2	2	3	3	3	2	2	2	2	2
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	0	1	2	2	3	3	4	4	5	6	6	7
Liabilities	14	14	10	50	13	18	25	26	27	21	28	21
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	819	814	809	804	657	652	646	632	627	622	617	613
Stockholders Equity
Stockholders Equity	152	164	177	190	96	109	131	147	173	200	220	245
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	-0	-0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-667	-649	-632	-615	-561	-543	-515	-485	-454	-422	-397	-368
Liabilities And Stockholders Equity	166	178	188	240	108	127	156	173	200	221	248	266
Preferred Stock Par Or Stated Value Per Share	-	-	-	0	-	-	-	0	-	-	-	0
Preferred Stock Shares Authorized	-	-	-	50	-	-	-	50	-	-	-	50
Preferred Stock Shares Issued	-	-	-	0	-	-	-	0	-	-	-	0
Preferred Stock Shares Outstanding	-	-	-	0	-	-	-	0	-	-	-	0
Common Stock Par Or Stated Value Per Share	-	-	-	0	-	-	-	0	-	-	-	0
Common Stock Shares Authorized	-	-	-	500	-	-	-	500	-	-	-	500
Common Stock Shares Issued	-	-	-	132	-	-	-	34	-	-	-	4
Shares Outstanding	-	-	-	132	-	-	-	34	-	-	-	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	10.62%	31.72%	107.97%	11.02%	157.37%	188.10%	16.39%	21.97%	98.45%	-	-	-
2024	-13.95%	-34.55%	-28.33%	-12.92%	-16.95%	-19.92%	-39.37%	-4.02%	-34.48%	8.93%	-21.52%	9.82%
2023	10.03%	-1.32%	24.80%	-15.94%	-30.66%	-52.94%	44.34%	93.64%	105.78%	-3.23%	-12.72%	-54.96%
2022	-	-	-	-	-	-	-19.93%	-9.92%	27.21%	-16.50%	-3.05%	5.84%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	12.04	13.25	21.11	4.87	9.90	8.14	7.01	7.41	8.57	13.46	10.86	17.77
Quick Ratio	11.76	12.95	20.66	4.78	9.45	7.76	6.69	7.28	8.46	13.30	10.72	17.51
Working Capital	147.67M	159.82M	174.52M	186.89M	92.24M	105.70M	127.19M	139.95M	165.29M	192.00M	212.98M	238.47M
Leverage & Debt
Debt to Equity	0.09	0.09	0.06	0.27	0.14	0.16	0.19	0.18	0.16	0.11	0.13	0.09
Debt Ratio	0.08	0.08	0.05	0.21	0.12	0.14	0.16	0.15	0.13	0.10	0.11	0.08
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Per Share Metrics
Diluted EPS TTM	-3.92	-3.95	-0.54	-3.19	-22.10	-24.79	-3.06	-3.05	-22.71	-20.61	-19.36	-20.61
Free Cash Flow Per Share TTM	-3.21	-3.41	-0.50	-2.05	-20.73	-21.64	-2.74	-2.56	-19.45	-18.48	-15.73	-17.61
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-10,900.68%	-5,618.53%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-10,456.09%	-5,490.37%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-72.59%	-59.95%
Net Income Growth (1Y)	-1.73%	-11.58%	-1.30%	11.19%	-1.27%	21.97%	27.43%	39.31%	38.14%	29.52%	26.63%	21.15%
EPS Growth (1Y)	-82.28%	-84.06%	-82.30%	4.58%	-2.65%	20.28%	-84.21%	-85.22%	21.30%	5.23%	-2.17%	1.97%
Calculated Values
Free Cash Flow TTM	-86.66M	-91.85M	-108.69M	-83.42M	-100.80M	-105.12M	-106.00M	-98.17M	-93.25M	-88.53M	-75.25M	-71.62M
Net Debt	-37.93M	-41.89M	-60.26M	-169.74M	-37.90M	-37.08M	-45.32M	-47.48M	-54.14M	-50.16M	-45.77M	-38.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-01-05Sale

Owner: Brockstedt, Dirk G.

Title: CHIEF SCIENTIFIC OFFICER

Shares: 898

Price/Share: $22.78

Value: $20,456.44

Shares Owned: 27,820

Relationship: Officer

Ownership: Direct

2023-12-21Sale

Owner: Ho, William

Title: Chief Medical Officer

Shares: 2,500

Price/Share: $21.68

Value: $54,200.00

Shares Owned: 15,020

Relationship: Officer

Ownership: Direct

2023-11-28Sale

Owner: Ho, William

Title: Chief Medical Officer

Shares: 1,500

Price/Share: $13.72

Value: $20,580.00

Shares Owned: 17,520

Relationship: Officer

Ownership: Direct

2023-10-03Sale

Owner: Ho, William

Title: Chief Medical Officer

Shares: 2,500

Price/Share: $15.77

Value: $39,425.00

Shares Owned: 18,789

Relationship: Officer

Ownership: Direct

2023-08-18Sale

Owner: Ho, William

Title: Chief Medical Officer

Shares: 2,500

Price/Share: $18.92

Value: $47,300.00

Shares Owned: 21,289

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-01-05	Brockstedt, Dirk G.	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	898	22.78	$20,456.44	27,820	4
2023-12-21	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,500	21.68	$54,200.00	15,020	4
2023-11-28	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,500	13.72	$20,580.00	17,520	4
2023-10-03	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,500	15.77	$39,425.00	18,789	4
2023-08-18	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,500	18.92	$47,300.00	21,289	4
2023-04-19	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	18.88	$94,400.00	20,992	4
2023-03-14	Robbins, Wendye	Director	-	Direct	Purchase	2,500	19.06	$47,650.00	14,900	4
2023-03-07	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	29.62	$148,100.00	25,532	4
2023-01-24	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	30.00	$150,000.00	30,072	4
2023-01-19	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	25.56	$127,800.00	35,072	4
2023-01-05	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	742	21.97	$16,301.74	19,070	4
2022-12-29	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	18.03	$90,150.00	37,650	4
2022-11-28	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	17.87	$89,350.00	42,650	4
2022-11-02	Ho, William	Officer	Chief Medical Officer	Direct	Sale	5,000	22.32	$111,600.00	47,650	4
2022-10-13	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	21.52	$43,040.00	52,650	4
2022-08-30	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,500	28.13	$70,325.00	53,035	4
2022-07-11	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	19.95	$39,900.00	52,306	4
2022-05-25	Kutzkey, Tim, Column Grou…	TenPercentOwner	-	Indirect	Purchase	1,900	12.45	$23,655.00	1,236,261	4
2022-05-25	Column, Group Ii, Lp, Col…	TenPercentOwner	-	Indirect	Purchase	1,900	12.45	$23,655.00	1,236,261	4
2022-05-24	Ponoi, Management, Llc, P…	TenPercentOwner	-	Indirect	Purchase	16,314	12.00	$195,768.00	1,234,424	4
2022-05-24	Column, Group Iv-A, Lp, C…	TenPercentOwner	-	Indirect	Purchase	16,314	12.00	$195,768.00	1,234,424	4
2022-05-10	Robbins, Wendye	Director	-	Direct	Purchase	4,500	11.17	$50,265.00	13,800	4
2022-05-10	Column, Group Llc, Column…	TenPercentOwner	-	Indirect	Purchase	1,250,000	10.67	$13,337,500.00	1,208,750	4
2022-05-10	Column, Group Iv-A, Lp, C…	TenPercentOwner	-	Indirect	Purchase	1,250,000	10.67	$13,337,500.00	1,208,750	4
2022-05-10	Young, Rodney Kb	Officer	Chief Financial Officer	Direct	Purchase	5,000	10.53	$52,650.00	10,084	4
2022-05-04	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	720	15.05	$10,836.00	19,812	4
2022-04-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	23.05	$61,013.35	19,812	4
2022-04-06	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	22.96	$68,880.00	53,386	4
2022-03-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	23.91	$63,313.68	19,812	4
2022-02-28	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	18.79	$56,370.00	55,691	4
2022-02-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	22.47	$59,478.09	19,812	4
2022-01-13	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	30.67	$92,010.00	57,884	4
2022-01-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	32.16	$85,159.68	19,812	4
2022-01-05	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	40.00	$80,000.00	60,884	4
2021-12-10	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	30.88	$81,739.36	19,812	4
2021-12-03	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	32.26	$96,780.00	57,106	4
2021-11-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	35.69	$94,507.12	19,812	4
2021-10-18	Robbins, Wendye	Director	-	Direct	Purchase	500	30.70	$15,350.00	9,300	4
2021-10-13	Robbins, Wendye	Director	-	Direct	Purchase	400	29.69	$11,876.00	8,800	4
2021-10-13	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	29.69	$89,070.00	60,106	4
2021-10-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	30.78	$81,474.66	19,812	4
2021-09-27	Ponoi, Capital Ii, Lp, Co…	TenPercentOwner	-	Indirect	Sale	9,239	34.80	$321,517.20	0	4
2021-09-20	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	40.00	$80,000.00	63,106	4
2021-09-17	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	38.92	$77,840.00	63,106	4
2021-09-15	Column, Group Ii, Lp, Goe…	TenPercentOwner	-	Indirect	Sale	33,535	37.45	$1,255,885.75	0	4
2021-09-13	Ponoi, Ii Management, Llc…	TenPercentOwner	-	Indirect	Sale	14,317	35.27	$504,960.59	36,633	4
2021-09-10	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	35.78	$94,745.44	19,812	4
2021-09-08	Ho, William	Officer	Chief Medical Officer	Direct	Sale	3,000	36.04	$108,120.00	65,106	4
2021-09-02	Column, Group Llc, Column…	TenPercentOwner	-	Indirect	Sale	37,101	35.43	$1,314,488.43	0	4
2021-08-24	Robbins, Wendye	Director	-	Indirect	Purchase	525	30.90	$16,222.50	2,000	4
2021-08-24	Svennilson, Peter, Column…	TenPercentOwner	-	Indirect	Sale	22,867	31.31	$715,965.77	0	4
2021-08-20	Robbins, Wendye	Director	-	Direct	Purchase	600	29.64	$17,784.00	8,400	4
2021-08-16	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	32.07	$32,070.00	68,106	4
2021-08-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	31.19	$82,559.93	19,812	4
2021-08-02	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	30.52	$30,520.00	64,722	4
2021-07-15	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	30.23	$30,230.00	57,529	4
2021-07-12	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	33.53	$88,787.44	19,812	4
2021-07-07	Robbins, Wendye	Director	-	Direct	Purchase	1,000	30.17	$30,170.00	7,800	4
2021-07-01	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	31.75	$31,750.00	58,529	4
2021-06-16	Robbins, Wendye	Director	-	Direct	Purchase	700	31.54	$22,078.00	6,800	4
2021-06-15	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	43.26	$43,260.00	59,529	4
2021-06-14	Ho, William	Officer	Chief Medical Officer	Direct	Sale	2,000	40.00	$80,000.00	60,529	4
2021-06-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,647	18.55	$49,101.85	19,812	4
2021-06-01	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	19.50	$19,500.00	62,529	4
2021-05-17	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	19.87	$19,870.00	63,529	4
2021-05-11	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,648	18.19	$48,167.12	19,812	4
2021-05-05	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	2,084	21.56	$44,931.04	19,812	4
2021-05-03	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	22.04	$22,040.00	64,529	4
2021-04-15	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	21.14	$21,140.00	63,445	4
2021-04-13	Robbins, Wendye	Director	-	Direct	Purchase	700	19.45	$13,615.00	6,100	4
2021-04-09	Robbins, Wendye	Director	-	Direct	Purchase	600	21.04	$12,624.00	5,400	4
2021-04-01	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	22.66	$22,660.00	64,445	4
2021-03-15	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	21.91	$21,910.00	65,445	4
2021-03-01	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	18.60	$18,600.00	66,445	4
2021-02-16	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	9,877	21.22	$209,589.94	19,812	4
2021-02-16	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	21.81	$21,810.00	67,445	4
2021-02-01	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	19.99	$19,990.00	66,414	4
2021-01-15	Ho, William	Officer	Chief Medical Officer	Direct	Sale	1,000	21.05	$21,050.00	67,414	4
2021-01-06	Brockstedt, Dirk G.	Officer	Chief Scientific Officer	Direct	Sale	1,179	19.68	$23,202.72	17,556	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

100.76%

Inst. Shares: 27,167,153

Shares Outstanding: 26,963,107

2025-09-30

50.42%

Inst. Shares: 13,595,434

Shares Outstanding: 26,963,107

2025-06-30

57.57%

Inst. Shares: 15,515,206

Shares Outstanding: 26,949,752

2025-03-31

60.55%

Inst. Shares: 130,425,178

Shares Outstanding: 215,410,253

2024-12-31

Inst. Shares: 125,751,964

Shares Outstanding: 40,761,143

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	27,167,153	26,963,107	100.76%
2025-09-30	13,595,434	26,963,107	50.42%
2025-06-30	15,515,206	26,949,752	57.57%
2025-03-31	130,425,178	215,410,253	60.55%
2024-12-31	125,751,964	40,761,143	-
2024-09-30	28,667,731	4,862,935	-
2024-06-30	30,968,993	4,858,345	-
2024-03-31	29,450,413	38,625,365	76.25%
2023-12-31	29,425,476	38,338,161	76.75%
2023-09-30	29,788,700	4,794,754	-
2023-06-30	28,746,409	4,791,093	-
2023-03-31	26,877,431	4,785,067	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

RAPT Therapeutics, Inc. (RAPT) — SEC Financial Statements & Analysis

RAPT Therapeutics, Inc. (RAPT) is a pharmaceutical preparations company, incorporated in DE. RAPT Therapeutics, Inc. trades on Nasdaq as: RAPT. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), RAPT Therapeutics, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.09x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.09x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RAPT Therapeutics, Inc. in?

RAPT Therapeutics, Inc. (RAPT) operates in the Pharmaceutical Preparations industry.

What exchange does RAPT trade on?

RAPT Therapeutics, Inc. (RAPT) trades on the Nasdaq.

Where is RAPT Therapeutics, Inc. incorporated?

RAPT Therapeutics, Inc. is incorporated in DE.